SCHEMBL22979609

SCHEMBL22979609

Cc1cccc(C#N)c1NC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.48
ALDH1A1 P00352 5/20 0.45
KDM4E B2RXH2 3/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
POLB P06746 2/20 0.44
NPC1 O15118 1/20 0.43
GAA P10253 5/20 0.43
LMNA P02545 2/20 0.43
L3MBTL1 Q9Y468 3/20 0.42
CXCR2 P25025 1/20 0.42
PTPRC P08575 1/20 0.41
ACP1 P24666 1/20 0.41
PTPN7 P35236 1/20 0.41
PTPN12 Q05209 1/20 0.41
PTPN22 Q9Y2R2 1/20 0.41
MEN1 O00255 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19779388 0.85 NLRP3 (0.44) TSHRALDH1A1KDM4ESMN1; SMN2TDP1
SCHEMBL22432781 0.83 ALDH1A1 (0.49) TSHRALDH1A1KDM4ENPC1GAA
SCHEMBL1620159 0.81 RAB9A (0.49) ALDH1A1SMN1; SMN2POLBNPC1LMNA
SCHEMBL22979056 0.81 GAA (0.41) TSHRALDH1A1KDM4ETDP1POLB
SCHEMBL22979896 0.81 GAA (0.43) TSHRALDH1A1KDM4ESMN1; SMN2TDP1
SCHEMBL21995607 0.81 KMT2A (0.45) ALDH1A1KDM4EPOLBNPC1GAA
SCHEMBL4333871 0.80 POLB (0.60) ALDH1A1POLBGAALMNAL3MBTL1
SCHEMBL22979601 0.80 LMNA (0.43) TSHRALDH1A1KDM4ESMN1; SMN2TDP1
SCHEMBL22979105 0.80 IMPDH2 (0.48) TSHRALDH1A1SMN1; SMN2POLBNPC1
SCHEMBL11055492 0.79 DRD2 (0.51) TSHRALDH1A1KDM4ESMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230113037-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES BAYER AKTIENGESELLSCHAFT (DE) 2023-04-13 US disclosed
EP-4013508-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES Bayer Aktiengesellschaft (DE) 2022-06-22 EP disclosed
WO-2021028382-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES BAYER AKTIENGESELLSCHAFT (DE) 2021-02-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230113037-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES AHR, HRH4, HRH1 TSHR 838/4885ALDH1A1 597/4885KDM4E 1364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.